Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus misoprostol versus misoprostol alone for first-trimester missed miscarriage
PACTR202510834974517Phase 3Completed
- Sponsor
- Principal Investigator
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of letrozole and misoprostol in missed abortion (2 arms), sponsored by Principal Investigator. Primary endpoints: Rate of complete abortion and Time to complete expulsion. Started Oct 2023; status: completed.
02
Drugs
letrozolemisoprostol
03
Conditions
missed abortion
Beyond the preview
Go deeper on PACTR202510834974517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510834974517.